Understanding the Polo Kinase machine

Oncogene

Volumn 34, Issue 37, 2015, Pages 4799-4807

  Archambault, V ^a   Lepine G ^a   Kachaner, D ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLO LIKE KINASE; CELL CYCLE PROTEIN; MULTIPROTEIN COMPLEX; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

CELL DIVISION; COMPLEX FORMATION; CRYSTAL STRUCTURE; CYTOKINESIS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME STRUCTURE; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; ANIMAL; CELL CYCLE CHECKPOINT; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL DIVISION; HUMANS; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS;

EID: 84941314826     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.451     Document Type: Review

References (121)

1. Sunkel CE, Glover DM. Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 1988; 89: 25-38.
2. Llamazares S, Moreira A, Tavares A, Girdham C, Spruce BA, Gonzalez C et al. Polo encodes a protein kinase homolog required for mitosis in Drosophila. Genes Dev 1991; 5: 2153-2165.
3. Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol 2009; 10: 265-275.
4. Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol 2014; 15: 433-452.
5. Hartwell LH, Mortimer RK, Culotti J, Culotti M. Genetic Control of the Cell Division Cycle in Yeast: V. Genetic Analysis of cdc Mutants. Genetics 1973; 74: 267-286.
6. Lee KS, Grenfell TZ, Yarm FR, Erikson RL. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc Natl Acad Sci USA 1998; 95: 9301-9306.
7. Elia AE, Cantley LC, Yaffe MB. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 2003; 299: 1228-1231.
8. Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K et al. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 2003; 115: 83-95.
9. de Carcer G, Manning G, Malumbres M. From Plk1 to Plk5: functional evolution of polo-like kinases. Cell Cycle 2011; 10: 2255-2262.
10. Karpov PA, Nadezhdina ES, Yemets AI, Matusov VG, Nyporko AY, Shashina NY et al. Bioinformatic search of plant microtubule-and cell cycle related serine-threonine protein kinases. BMC Genomics 2010; 11: S14.
11. Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. J Cell Biol 1996; 135: 1701-1713.
12. Sutterlin C, Lin CY, Feng Y, Ferris DK, Erikson RL, Malhotra V. Polo-like kinase is required for the fragmentation of pericentriolar Golgi stacks during mitosis. Proc Natl Acad Sci USA 2001; 98: 9128-9132.
13. Golsteyn RM, Mundt KE, Fry AM, Nigg EA. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J Cell Biol 1995; 129: 1617-1628.
14. Sumara I, Gimenez-Abian JF, Gerlich D, Hirota T, Kraft C, de la Torre C et al. Roles of polo-like kinase 1 in the assembly of functional mitotic spindles. Curr Biol 2004; 14: 1712-1722.
15. Elowe S, Hummer S, Uldschmid A, Li X, Nigg EA. Tension-sensitive Plk1 phosphorylation on BubR1 regulates the stability of kinetochore microtubule interactions. Genes Dev 2007; 21: 2205-2219.
16. Lenart P, Petronczki M, Steegmaier M, Di Fiore B, Lipp JJ, Hoffmann M et al. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1. Curr Biol 2007; 17: 304-315.
17. McKinley KL, Cheeseman IM. Polo-like kinase 1 licenses CENP-A deposition at centromeres. Cell 2014; 158: 397-411.
18. Neef R, Gruneberg U, Kopajtich R, Li X, Nigg EA, Sillje H et al. Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1. Nat Cell Biol 2007; 9: 436-444.
19. Burkard ME, Randall CL, Larochelle S, Zhang C, Shokat KM, Fisher RP et al. Chemical genetics reveals the requirement for Polo-like kinase 1 activity in positioning RhoA and triggering cytokinesis in human cells. Proc Natl Acad Sci USA 2007; 104: 4383-4388.
20. Brennan IM, Peters U, Kapoor TM, Straight AF. Polo-like kinase controls vertebrate spindle elongation and cytokinesis. PLoS One 2007; 2: e409.
21. Petronczki M, Glotzer M, Kraut N, Peters JM. Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle. Dev Cell 2007; 12: 713-725.
22. Santamaria A, Neef R, Eberspacher U, Eis K, Husemann M, Mumberg D et al. Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosis. Mol Biol Cell 2007; 18: 4024-4036.
23. Wu ZQ, Liu X. Role for Plk1 phosphorylation of Hbo1 in regulation of replication licensing. Proc Natl Acad Sci USA 2008; 105: 1919-1924.
24. Seki A, Coppinger JA, Jang CY, Yates JR, Fang G. Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry.Science 2008; 320: 1655-1658.
25. Sumara I, Vorlaufer E, Stukenberg PT, Kelm O, Redemann N, Nigg EA et al. The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol Cell 2002; 9: 515-525.
26. Abe S, Nagasaka K, Hirayama Y, Kozuka-Hata H, Oyama M, Aoyagi Y et al. The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II. Genes Dev 2011; 25: 863-874.
27. Bettencourt-Dias M, Rodrigues-Martins A, Carpenter L, Riparbelli M, Lehmann L, Gatt MK et al. SAK/PLK4 is required for centriole duplication and flagella development. Curr Biol 2005; 15: 2199-2207.
28. Habedanck R, Stierhof YD, Wilkinson CJ, Nigg EA. The Polo kinase Plk4 functions in centriole duplication. Nat Cell Biol 2005; 7: 1140-1146.
29. Warnke S, Kemmler S, Hames RS, Tsai HL, Hoffmann-Rohrer U, Fry AM et al. Polo-like kinase-2 is required for centriole duplication in mammalian cells. Curr Biol 2004; 14: 1200-1207.
30. Myer DL, Bahassi el M, Stambrook PJ. The Plk3-Cdc25 circuit. Oncogene 2005; 24: 299-305.
31. Zimmerman WC, Erikson RL. Polo-like kinase 3 is required for entry into S phase. Proc Natl Acad Sci USA 2007; 104: 1847-1852.
32. Burns TF, Fei P, Scata KA, Dicker DT, El-Deiry WS. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 2003; 23: 5556-5571.
33. Matthew EM, Yen TJ, Dicker DT, Dorsey JF, Yang W, Navaraj A et al. Replication stress, defective S-phase checkpoint and increased death in Plk2-deficient human cancer cells. Cell Cycle 2007; 6: 2571-2578.
34. Xie S, Wu H, Wang Q, Cogswell JP, Husain I, Conn C et al. Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. J Biol Chem 2001; 276: 43305-43312.
35. Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y et al. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene 2002; 21: 6633-6640.
36. Kauselmann G, Weiler M, Wulff P, Jessberger S, Konietzko U, Scafidi J et al. The polo-like protein kinases Fnk and Snk associate with a Ca(2+)-and integrin-binding protein and are regulated dynamically with synaptic plasticity. EMBO J 1999; 18: 5528-5539.
37. Seeburg DP, Feliu-Mojer M, Gaiottino J, Pak DT, Sheng M. Critical role of CDK5 and Polo-like kinase 2 in homeostatic synaptic plasticity during elevated activity. Neuron 2008; 58: 571-583.
38. de Carcer G, Escobar B, Higuero AM, Garcia L, Anson A, Perez G et al. Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression. Mol Cell Biol 2011; 31: 1225-1239.
39. Andrysik Z, Bernstein WZ, Deng L, Myer DL, Li YQ, Tischfield JA et al. The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus. Nucleic Acids Res 2010; 38: 2931-2943.
40. Petronczki M, Lenart P, Peters JM. Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1. Dev Cell 2008; 14: 646-659.
41. Strebhardt K. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nat Rev Drug Discov 2010; 9: 643-660.
42. Murugan RN, Park JE, Kim EH, Shin SY, Cheong C, Lee KS et al. Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity. Mol Cells 2011; 32: 209-220.
43. Gjertsen BT, Schoffski P. Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy. Leukemia 2015; 29: 11-19.
44. Jang YJ, Lin CY, Ma S, Erikson RL. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase. Proc Natl Acad Sci USA 2002; 99: 1984-1989.
45. Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex. EMBO J 2003; 22: 5757-5768.
46. Lowery DM, Lim D, Yaffe MB. Structure and function of Polo-like kinases. Oncogene 2005; 24: 248-259.
47. Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH et al. Polo-box domain: a versatile mediator of polo-like kinase function. Cell Mol Life Sci 2010; 67: 1957-1970.
48. Taniguchi E, Toyoshima-Morimoto F, Nishida E. Nuclear translocation of plk1 mediated by its bipartite nuclear localization signal. J Biol Chem 2002; 277: 48884-48888.
49. Mundt KE, Golsteyn RM, Lane HA, Nigg EA. On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. Biochem Biophys Res Commun 1997; 239: 377-385.
50. Xu J, Shen C, Wang T, Quan J. Structural basis for the inhibition of Polo-like kinase 1. Nat Struct Mol Biol 2013; 20: 1047-1053.
51. Archambault V, D'Avino PP, Deery MJ, Lilley KS, Glover DM. Sequestration of Polo kinase to microtubules by phosphopriming-independent binding to Map205 is relieved by phosphorylation at a CDK site in mitosis. Genes Dev 2008; 22: 2707-2720.
52. Kothe M, Kohls D, Low S, Coli R, Cheng AC, Jacques SL et al. Structure of the catalytic domain of human polo-like kinase 1. Biochemistry 2007; 46: 5960-5971.
53. Santamaria A, Wang B, Elowe S, Malik R, Zhang F, Bauer M et al. The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics 2010; 10: M110 004457.
54. Nakajima H, Toyoshima-Morimoto F, Taniguchi E, Nishida E. Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J Biol Chem 2003; 278: 25277-25280.
55. Archambault V, Carmena M. Polo-like kinase-activating kinases: Aurora A, Aurora B and what else? Cell Cycle 2012; 11: 1490-1495.
56. Bruinsma W, Raaijmakers JA, Medema RH. Switching Polo-like kinase-1 on and off in time and space. Trends Biochem Sci 2013; 37: 534-542.
57. Ferrari S, Marin O, Pagano MA, Meggio F, Hess D, El-Shemerly M et al. Aurora-A site specificity: a study with synthetic peptide substrates. Biochem J 2005; 390: 293-302.
58. Jang YJ, Ma S, Terada Y, Erikson RL. Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase. J Biol Chem 2002; 277: 44115-44120.
59. Qian YW, Erikson E, Maller JL. Mitotic effects of a constitutively active mutant of the Xenopus polo-like kinase Plx1. Mol Cell Biol 1999; 19: 8625-8632.
60. Macurek L, Lindqvist A, Lim D, Lampson MA, Klompmaker R, Freire R et al. Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery. Nature 2008; 455: 119-123.
61. Bruinsma W, Macurek L, Freire R, Lindqvist A, Medema RH. Bora and Aurora-A continue to activate Plk1 in mitosis. J Cell Sci 2014; 127: 801-811.
62. Carmena M, Pinson X, Platani M, Salloum Z, Xu Z, Clark A et al. The chromosomal passenger complex activates Polo kinase at centromeres. PLoS Biol 2012; 10: e1001250.
63. Carmena M, Ruchaud S, Earnshaw WC. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol 2009; 21: 796-805.
64. Carmena M, Wheelock M, Funabiki H, Earnshaw WC. The chromosomal passenger complex (CPC): from easy rider to the godfather of mitosis. Nat Rev Mol Cell Biol 2012; 13: 789-803.
65. Kachaner D, Pinson X, El Kadhi KB, Normandin K, Talje L, Lavoie H et al. Interdomain allosteric regulation of Polo kinase by Aurora B and Map205 is required for cytokinesis. J Cell Biol 2014; 207: 201-211.
66. Mortensen EM, Haas W, Gygi M, Gygi SP, Kellogg DR. Cdc28-dependent regulation of the Cdc5/Polo kinase. Curr Biol 2005; 15: 2033-2037.
67. Lindqvist A, Rodriguez-Bravo V, Medema RH. The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 2009; 185: 193-202.
68. van de Weerdt BC, van Vugt MA, Lindon C, Kauw JJ, Rozendaal MJ, Klompmaker R et al. Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1. Mol Cell Biol 2005; 25: 2031-2044.
69. Kasahara K, Goto H, Izawa I, Kiyono T, Watanabe N, Elowe S et al. PI 3-kinasedependent phosphorylation of Plk1-Ser99 promotes association with 14-3-3gamma and is required for metaphase-anaphase transition. Nat Commun 2013. 4-1882.
70. Maroto B, Ye MB, von Lohneysen K, Schnelzer A, Knaus UG. P21-activated kinase is required for mitotic progression and regulates Plk1. Oncogene 2008; 27: 4900-4908.
71. Yamashiro S, Yamakita Y, Totsukawa G, Goto H, Kaibuchi K, Ito M et al. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1. Dev Cell 2008; 14: 787-797.
72. Paschal CR, Maciejowski J, Jallepalli PV. A stringent requirement for Plk1 T210 phosphorylation during K-fiber assembly and chromosome congression. Chromosoma 2012; 121: 565-572.
73. Lindon C, Pines J. Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells. J Cell Biol 2004; 164: 233-241.
74. Kachaner D, Filipe J, Laplantine E, Bauch A, Bennett KL, Superti-Furga G et al. Plk1-dependent phosphorylation of optineurin provides a negative feedback mechanism for mitotic progression. Mol Cell 2012; 45: 553-566.
75. Kong D, Farmer V, Shukla A, James J, Gruskin R, Kiriyama S et al. Centriole maturation requires regulated Plk1 activity during two consecutive cell cycles. J Cell Biol 2014; 206: 855-865.
76. Matsumura F, Yamakita Y, Yamashiro S. Myosin phosphatase-targeting subunit 1 controls chromatid segregation. J Biol Chem 2011; 286: 10825-10833.
77. Eckl JM, Richter K. Functions of the Hsp90 chaperone system: lifting client proteins to new heights. Int J Biochem Mol Biol 2014; 4: 157-165.
78. de Carcer G. Heat shock protein 90 regulates the metaphase-anaphase transition in a polo-like kinase-dependent manner. Cancer Res 2004; 64: 5106-5112.
79. de Carcer G, do Carmo Avides M, Lallena MJ, Glover DM, Gonzalez C. Requirement of Hsp90 for centrosomal function reflects its regulation of Polo kinase stability. EMBO J 2001; 20: 2878-2884.
80. Martins T, Maia AF, Steffensen S, Sunkel CE. Sgt1, a co-chaperone of Hsp90 stabilizes Polo and is required for centrosome organization. EMBO J 2009; 28: 234-247.
81. Enserink JM, Kolodner RD. An overview of Cdk1-controlled targets and processes. Cell Div 2010; 5: 11.
82. Watanabe N, Arai H, Iwasaki J, Shiina M, Ogata K, Hunter T et al. Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways. Proc Natl Acad Sci USA 2005; 102: 11663-11668.
83. Kang YH, Park JE, Yu LR, Soung NK, Yun SM, Bang JK et al. Self-regulated Plk1 recruitment to kinetochores by the Plk1-PBIP1 interaction is critical for proper chromosome segregation. Mol Cell 2006; 24: 409-422.
84. Garcia-Alvarez B, de Carcer G, Ibanez S, Bragado-Nilsson E, Montoya G. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization. Proc Natl Acad Sci USA 2007; 104: 3107-3112.
85. Goldstein LS, Laymon RA, McIntosh JR. A microtubule-associated protein in Drosophila melanogaster: identification, characterization, and isolation of coding sequences. J Cell Biol 1986; 102: 2076-2087.
86. Liu F, Park JE, Qian WJ, Lim D, Graber M, Berg T et al. Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. Nat Chem Biol 2011; 7: 595-601.
87. Sledz P, Stubbs CJ, Lang S, Yang YQ, McKenzie GJ, Venkitaraman AR et al. From crystal packing to molecular recognition: prediction and discovery of a binding site on the surface of polo-like kinase 1. Angew Chem Int Ed Engl 2011; 50: 4003-4006.
88. Chen YC, Weinreich M. Dbf4 regulates the Cdc5 Polo-like kinase through a distinct non-canonical binding interaction. J Biol Chem 2010; 285: 41244-41254.
89. Sclafani RA. Cdc7p-Dbf4p becomes famous in the cell cycle. J Cell Sci 2000; 113: 2111-2117.
90. Miller CT, Gabrielse C, Chen YC, Weinreich M. Cdc7p-Dbf4p regulates mitotic exit by inhibiting Polo kinase. PLoS Genet 2009; 5: e1000498.
91. Xiang Y, Takeo S, Florens L, Hughes SE, Huo LJ, Gilliland WD et al. The inhibition of Polo Kinase by matrimony maintains G2 arrest in the meiotic cell cycle. PLoS Biol 2007; 5: e323.
92. Smith SK, Jaspersen SL, Hawley RS. Matrimony ties Polo down: can this kinase get free? Cell Cycle 2008; 7: 698-701.
93. Whitfield ZJ, Chisholm J, Hawley RS, Orr-Weaver TL. A meiosis-specific form of the APC/C promotes the oocyte-to-embryo transition by decreasing levels of the Polo kinase inhibitor matrimony. PLoS Biol 2013; 11: e1001648.
94. Bonner AM, Hughes SE, Chisholm JA, Smith SK, Slaughter BD, Unruh JR et al. Binding of Drosophila Polo kinase to its regulator Matrimony is noncanonical and involves two separate functional domains. Proc Natl Acad Sci USA 2013; 110: E1222-E1231.
95. Beck J, Maerki S, Posch M, Metzger T, Persaud A, Scheel H et al. Ubiquitylationdependent localization of PLK1 in mitosis. Nat Cell Biol 2013; 15: 430-439.
96. Zhai B, Villen J, Beausoleil SA, Mintseris J, Gygi SP. Phosphoproteome analysis of Drosophila melanogaster embryos. J Proteome Res 2008; 7: 1675-1682.
97. Petersen J, Hagan IM. Polo kinase links the stress pathway to cell cycle control and tip growth in fission yeast. Nature 2005; 435: 507-512.
98. Craig SN, Wyatt MD, McInnes C. Current assessment of polo-like kinases as anti-tumor drug targets. Expert Opin Drug Discov 2014; 9: 773-789.
99. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 2009; 137: 835-848.
100. Liu X, Lei M, Erikson RL. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol Cell Biol 2006; 26: 2093-2108.
101. Renner AG, Dos Santos C, Recher C, Bailly C, Creancier L, Kruczynski A et al. Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells. Blood 2009; 114: 659-662.
102. Rudolph D, Steegmaier M, Hoffmann M, Grauert M, Baum A, Quant J et al. BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity. Clin Cancer Res 2009; 15: 3094-3102.
103. Gilmartin AG, Bleam MR, Richter MC, Erskine SG, Kruger RG, Madden L et al. Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis. Cancer Res 2009; 69: 6969-6977.
104. McInnes C, Mazumdar A, Mezna M, Meades C, Midgley C, Scaerou F et al. Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol 2006; 2: 608-617.
105. Wolfe BA, Takaki T, Petronczki M, Glotzer M. Polo-like kinase 1 directs assembly of the HsCyk-4 RhoGAP/Ect2 RhoGEF complex to initiate cleavage furrow formation. PLoS Biol 2009; 7: e1000110.
106. Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009; 9: 28-39.
107. Steegmaier M, Hoffmann M, Baum A, Lenart P, Petronczki M, Krssak M et al. BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo. Curr Biol 2007; 17: 316-322.
108. van de Weerdt BC, Littler DR, Klompmaker R, Huseinovic A, Fish A, Perrakis A et al. Polo-box domains confer target specificity to the Polo-like kinase family. Biochim Biophys Acta 2008; 1783: 1015-1022.
109. Seong YS, Kamijo K, Lee JS, Fernandez E, Kuriyama R, Miki T et al. A spindle checkpoint arrest and a cytokinesis failure by the dominant-negative polo-box domain of Plk1 in U-2 OS cells. J Biol Chem 2002; 277: 32282-32293.
110. Hanisch A, Wehner A, Nigg EA, Sillje HH. Different Plk1 functions show distinct dependencies on Polo-Box domain-mediated targeting. Mol Biol Cell 2006; 17: 448-459.
111. Lera RF, Burkard ME. High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells. J Biol Chem 2012; 287: 42812-42825.
112. Qian WJ, Park JE, Lim D, Park SY, Lee KW, Yaffe MB et al. Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs. Chem Biol 2013; 20: 1255-1264.
113. Reindl W, Yuan J, Kramer A, Strebhardt K, Berg T. Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions. Chem Biol 2008; 15: 459-466.
114. Yuan J, Sanhaji M, Kramer A, Reindl W, Hofmann M, Kreis NN et al. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol 2011; 179: 2091-2099.
115. Yin Z, Song Y, Rehse PH. Thymoquinone blocks pSer/pThr recognition by Plk1 Polo-box domain as a phosphate mimic. ACS Chem Biol 2013; 8: 303-308.
116. Watanabe N, Sekine T, Takagi M, Iwasaki J, Imamoto N, Kawasaki H et al. Deficiency in chromosome congression by the inhibition of Plk1 polo box domain-dependent recognition. J Biol Chem 2009; 284: 2344-2353.
117. Liao C, Park JE, Bang JK, Nicklaus MC, Lee KS. Exploring potential binding modes of small drug-like molecules to the Polo-Box Domain of human Polo-like kinase 1. ACS Med Chem Lett 2010; 1: 110-114.
118. Ratsima H, Ladouceur AM, Pascariu M, Sauve V, Salloum Z, Maddox PS et al. Independent modulation of the kinase and polo-box activities of Cdc5 protein unravels unique roles in the maintenance of genome stability. Proc Natl Acad Sci USA 2011; 108: E914-E923.
119. McInnes C, Estes K, Baxter M, Yang Z, Farag DB, Johnston P et al. Targeting subcellular localization through the polo-box domain: non-ATP competitive inhibitors recapitulate a PLK1 phenotype. Mol Cancer Ther 2012; 11: 1683-1692.
120. Oshimori N, Ohsugi M, Yamamoto T. The Plk1 target Kizuna stabilizes mitotic centrosomes to ensure spindle bipolarity. Nat Cell Biol 2006; 8: 1095-1101.
121. Gardino AK, Yaffe MB. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol 2011; 22: 688-695.